menu
    • menu

    Company profile for Phanes Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in July 2016, Phanes is led by a team of industry veterans with extensive drug discovery and development experience in global pharma and biotech companies, including Pfizer, Amgen, and J&J. Our extensive experience and relentless pursuit of deep science strongly position us to discover and advance robust therapeutic molecules for patients. In addition to a strong pipeline, we have developed disruptive technologies that...
    Founded in July 2016, Phanes is led by a team of industry veterans with extensive drug discovery and development experience in global pharma and biotech companies, including Pfizer, Amgen, and J&J. Our extensive experience and relentless pursuit of deep science strongly position us to discover and advance robust therapeutic molecules for patients. In addition to a strong pipeline, we have developed disruptive technologies that enable drug discovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Phanes TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11535 Sorrento Valley Road, Suite 400 San Diego, CA 92121
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.phanesthera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phanes Therapeutics Doses First BTC Patient in Spevatamig Study
    Phanes Therapeutics Doses First BTC Patient in Spevatamig Study

    08 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-biliary-tract-carcinoma-btc-patient-dosed-in-clinical-study-of-spevatamig-in-combination-with-chemotherapy-302549488.html

    PR NEWSWIRE
    08 Sep 2025
    Share Share
    Phanes Therapeutics Doses First Patient in PT199 Clinical Study
    Phanes Therapeutics Doses First Patient in PT199 Clinical Study

    27 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-mavrostobart-pt199-in-combination-with-chemotherapy-302464552.html

    PR NEWSWIRE
    27 May 2025
    Share Share
    Phanes Therapeutics Doses First Patient in Peluntamig Study
    Phanes Therapeutics Doses First Patient in Peluntamig Study

    05 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-peluntamig-in-combination-with-atezolizumab-302446359.html

    PR NEWSWIRE
    05 May 2025
    Share Share
    Phanes 1st Patient Dosed in Peluntamig Study with Chemotherapy
    Phanes 1st Patient Dosed in Peluntamig Study with Chemotherapy

    19 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phanes-therapeutics-announces-first-patient-dosed-in-clinical-study-of-peluntamig-pt217-in-combination-with-chemotherapy-302380460.html

    PR NEWSWIRE
    19 Feb 2025
    Share Share
    FDA Grants Fast Track To Phanes’ PT217 For NEPC
    FDA Grants Fast Track To Phanes’ PT217 For NEPC

    04 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/phanes-therapeutics-pt217-granted-fast-track-designation-by-the-fda-for-nepc-302322839.html

    PR NEWSWIRE
    04 Dec 2024
    Share Share
    Veravas with Phanes Biotech on Tau Pathology Test for Alzheimer's
    Veravas with Phanes Biotech on Tau Pathology Test for Alzheimer's

    07 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241107809247/en

    BUSINESSWIRE
    07 Nov 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search